
HYDERABAD, India, Aug. 29, 2023 /PRNewswire/ — Aryastha Life Sciences, a leading Contract Research and Development Organization in healthcare, has achieved a major milestone by successfully concluding its Series A funding with significant backing from Vessella Group, a prominent investor in India.